Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19

NCT04591015 is registered in ClinicalTrials.gov with Scripps Whittier Diabetes Institute as lead sponsor.

NCT NCT04591015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19
Lead sponsor
Scripps Whittier Diabetes Institute
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
August 31, 2022
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, diabetes mellitus, type 2